The global impact and cost-effectiveness of a melioidosis vaccine

BMC Medicine
http://www.biomedcentral.com/bmcmed/content
(Accessed 6 Jul 2019)

 

Research article
The global impact and cost-effectiveness of a melioidosis vaccine
Every year, 90,000 people may die from melioidosis. Vaccine candidates have not proceeded past animal studies, partly due to uncertainty around the potential market size. This study aims to estimate the potent…
Authors: Nantasit Luangasanatip, Stefan Flasche, David A. B. Dance, Direk Limmathurotsakul, Bart J. Currie, Chiranjay Mukhopadhyay, Tim Atkins, Richard Titball and Mark Jit
Citation: BMC Medicine 2019 17:129
Published on: 5 July 2019